Better reporting of harms in randomized trials: an extension of the CONSORT statement.
about
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesWhy most published research findings are falseThe quality of reports on cervical arterial dissection following cervical spinal manipulationGuidelines for reporting health research: the EQUATOR network's survey of guideline authorsCognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysisStatistical issues in first-in-man studiesBiologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysisA comparison of different antibiotic regimens for the treatment of infective endocarditisGrowth factors for treating diabetic foot ulcersGloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital settingJanus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosisProbiotics for the prevention of pediatric antibiotic-associated diarrheaEarly versus delayed erythropoietin for the anaemia of end-stage kidney diseaseCorticosteroids for treating sepsisMycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipientsVitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseasesAntifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver diseaseInterventions for treating intrahepatic cholestasis in people with sickle cell diseaseAntibiotics for treating acute chest syndrome in people with sickle cell diseaseInterventions for treating leg ulcers in people with sickle cell diseaseProphylactic lidocaine for myocardial infarctionEculizumab for treating patients with paroxysmal nocturnal hemoglobinuriaAntibiotics for gonorrhoea in pregnancyImpact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer painAppetite stimulants for people with cystic fibrosisEliciting adverse effects data from participants in clinical trialsAntibiotic therapy for treatment of infective endocarditisSafety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviewsVitamin K for upper gastrointestinal bleeding in patients with acute or chronic liver diseasesAntifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver diseaseSafety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviewsErythropoiesis-stimulating agents for anemia in rheumatoid arthritisRoutine intraoperative ureteric stenting for kidney transplant recipientsVaccines for the common coldSafety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviewsOverview of the safety of regular formoterol or salmeterol in children with asthmaPharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyInterventions for treating leg ulcers in people with sickle cell diseaseAloe vera for treating acute and chronic woundsProbiotics for the prevention of pediatric antibiotic-associated diarrhea
P2860
Q21092368-D05CEBFA-BCF4-47FF-BAA0-1E6302982E01Q21092395-D348A234-CD67-4D20-95D1-A2AE4D74441EQ21133620-A6A93C39-05AE-4F24-8D6B-4DDA768A697DQ21563406-C1DDB5A3-B718-4379-A5FA-F8632FB47DDBQ22251382-2DA0BD6E-76FC-4F7F-891A-F97CE4D7B591Q23018507-23C3328D-8105-46D1-B234-766CEC2C9995Q24185797-EDB768E4-1789-4BBC-96AE-7006E4D57854Q24185887-3FBA9887-11CE-4BDE-9BBD-B5390EEEDD64Q24186333-4880D739-36DA-4713-9CDD-8A0305A5CE47Q24186422-E1115381-9BEE-476C-8ACC-86690B57943FQ24186554-B770D00E-0ABE-448C-B019-3C52EBA640BAQ24186991-980CB5DD-77BA-4B0D-83D1-BF0BAD7949B4Q24187089-E5B0DBFB-D4B0-4066-8FA3-7273B8A968D7Q24187207-AD25D803-0555-4320-AE7E-42F7A69E1FC5Q24187213-E53A3564-F52D-4743-BB65-00B0554B74E1Q24187239-CEDC2DA0-AE4E-4A6D-89E1-E99F1524C2FAQ24187246-3FC678DB-745A-4543-B59F-9E7E7B6BA6E5Q24187279-274953F1-7A52-44A8-9626-5C59101F9936Q24187355-0B209039-E57D-426A-AF1C-F88479E8CB90Q24187407-BC17224B-7411-4F30-944B-FD442842BE64Q24187816-812903B7-42B1-4E86-9995-4D83A0454FA6Q24193045-9A36782B-9F3D-41F7-BC35-9F95998F97B0Q24194307-2A9AC4CE-8789-4B1B-88BB-828D3DB81440Q24194524-FD375C47-A687-4294-A2FF-5E4C8F8818C6Q24194798-31B3FB53-D539-45F1-8E33-EEB9034DD88BQ24197537-35C944E5-18CE-433E-BEF7-36408BBC637FQ24198788-2AA261F4-5629-49BA-8C9D-DDB25FBE0A89Q24198890-46B8BEA6-775B-405D-913D-D4897141FCB7Q24200416-F7F51669-66B8-4F58-8A37-6938D4FC190FQ24200420-9D73D126-F4E4-41CA-9768-84AB20C3FEE8Q24200620-5C3CB38B-9877-4FAA-B795-D1CA1BC86F5CQ24200775-624923D7-99AC-4BB2-9DA8-7848551EA683Q24201937-52860A03-CDAA-4D41-984F-84344F96A065Q24201977-AD447608-6000-4E18-8414-C3EE5020E8AAQ24202052-CAF117FA-CDFE-4C0C-8579-B7FDA70A2126Q24202543-1CC63BA6-7AC4-4987-A903-C03B525C5C1FQ24202908-3ED77BC5-26DD-4F0C-863D-F83D93501E4EQ24202954-5934670D-1D4E-4F04-98DC-D29039FAE964Q24203699-EE8017FE-10D1-4056-9910-C196AEAC7D19Q24235039-61EA496F-88AC-466F-95C4-80F52A2CB66B
P2860
Better reporting of harms in randomized trials: an extension of the CONSORT statement.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Better reporting of harms in randomized trials: an extension of the CONSORT statement.
@ast
Better reporting of harms in randomized trials: an extension of the CONSORT statement.
@en
type
label
Better reporting of harms in randomized trials: an extension of the CONSORT statement.
@ast
Better reporting of harms in randomized trials: an extension of the CONSORT statement.
@en
prefLabel
Better reporting of harms in randomized trials: an extension of the CONSORT statement.
@ast
Better reporting of harms in randomized trials: an extension of the CONSORT statement.
@en
P2093
P50
P1476
Better reporting of harms in randomized trials: an extension of the CONSORT statement.
@en
P2093
CONSORT Group
Kenneth Schulz
Robert T O'Neill
Stephen J W Evans
P304
P356
10.7326/0003-4819-141-10-200411160-00009
P407
P577
2004-11-01T00:00:00Z